Mono-Linyah

Adult Dosing .

Dosage forms:  monophasic pack

Special Note

[monophasic pack components]

Info: 28-day pack contains norgestimate/ethinyl estradiol 0.25 mg/35 mcg tab x21, then inert tab x7

[additional info]

Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table

contraception

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysfunctional uterine bleeding, moderate (off-label)

[acute phase]

Dose: 1 tab PO bid x5-7 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs; Alt: 1 tab PO tid x3 days or until bleeding subsides, then 1 tab PO bid x3-5 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs

[maintenance phase]

Dose: 1 tab PO qd; Info: may skip inert tabs for extended or continuous cycle; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysmenorrhea (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

endometriosis (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

polycystic ovary syndrome (off-label)

[1 tab PO qd]

Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

renal dosing

[see below]

renal dz: not defined, caution advised

HD/PD: avoid use

hepatic dosing

[see below]

active hepatic dz: contraindicated

Peds Dosing .

Dosage forms:  monophasic pack

Special Note

[monophasic pack components]

Info: 28-day pack contains norgestimate/ethinyl estradiol 0.25 mg/35 mcg tab x21, then inert tab x7

[additional info]

Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table

contraception

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysfunctional uterine bleeding, moderate (off-label)

[acute phase, postmenarchal females]

Dose: 1 tab PO bid x5-7 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs; Alt: 1 tab PO tid x3 days or until bleeding subsides, then 1 tab PO bid x3-5 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs

[maintenance phase, postmenarchal females]

Dose: 1 tab PO qd; Info: may skip inert tabs for extended or continuous cycle; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

dysmenorrhea (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

endometriosis (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

polycystic ovary syndrome (off-label)

[postmenarchal females]

Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding

renal dosing

[see below]

renal dz: not defined, caution advised

HD/PD: avoid use

hepatic dosing

[see below]

active hepatic dz: contraindicated